Bened Biomedical Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
Bened Biomedical General Information
Description
Developer of microbiome-based therapeutic products designed to improve human health through beneficial bacterial applications. The company offers probiotic drug development, gut microbiome research, and bacterial strain cultivation technologies, enabling healthcare providers and individuals to address microbiome-related conditions and support digestive and neurological well-being.
Contact Information
Website
www.benedbiomed.comCorporate Office
- 8th Floor, Number 508, Section 7, Zhongxiao East Road
- Nangang District
- Taipei, 115
- Taiwan
Corporate Office
- 8th Floor, Number 508, Section 7, Zhongxiao East Road
- Nangang District
- Taipei, 115
- Taiwan
Bened Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Nov-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series A) | 18-Feb-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 13-Mar-2015 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bened Biomedical Patents
Bened Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260144832-A1 | Method for preventing or treating chronic pain | Pending | 27-Nov-2024 | ||
| WO-2025102265-A1 | Use of lacticaseibacillus bacteria for treating and/or preventing polycystic ovary syndrome | Inactive | 15-Nov-2023 | ||
| US-20260335382-A1 | Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage | Pending | 24-Oct-2022 | ||
| WO-2024086963-A1 | Lactic acid bacterium and method for preventing or minimizing exercise-induced muscle damage | Inactive | 24-Oct-2022 | ||
| WO-2024060118-A1 | Method for treating sleeping disorders with groel protein | Inactive | 22-Sep-2022 | A61P3/00 |
Bened Biomedical Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Maxpro Ventures | Venture Capital | Minority | ||
| JIF Capital | Venture Capital | Minority | ||
| Trans-Pacific Technology Fund | Venture Capital | Minority | ||
| B Current Impact Investment | Venture Capital | Minority | ||
| National Yang Ming Chiao Tung University | Corporation | Minority |
Bened Biomedical Acquisitions (1)
Bened Biomedical’s most recent deal was a Merger/Acquisition with Oryx Biomedical. The deal was made on 01-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Oryx Biomedical | 01-Jun-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Bened Biomedical FAQs
-
When was Bened Biomedical founded?
Bened Biomedical was founded in 2015.
-
Where is Bened Biomedical headquartered?
Bened Biomedical is headquartered in Taipei, Taiwan.
-
What industry is Bened Biomedical in?
Bened Biomedical’s primary industry is Drug Discovery.
-
Is Bened Biomedical a private or public company?
Bened Biomedical is a Private company.
-
What is Bened Biomedical’s current revenue?
The current revenue for Bened Biomedical is .
-
How much funding has Bened Biomedical raised over time?
Bened Biomedical has raised $10M.
-
Who are Bened Biomedical’s investors?
Maxpro Ventures, JIF Capital, Trans-Pacific Technology Fund, B Current Impact Investment, and National Yang Ming Chiao Tung University have invested in Bened Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process